Latest Comments on Robert Freedland's Articles

1. Sugar Charlie on Johnson & Johnson: A Compelling Investment Opportunity: Great stock, for the reasons given by RF, MG and others, but I... more »
2. MarkGillCPA on Johnson & Johnson: A Compelling Investment Opportunity: Agree - JNJ is a good solid core holding and is in my core equity... more »
3. retiredpharma on Johnson & Johnson: A Compelling Investment Opportunity: Sheldon, Your conservative pharma picks are all good and I would... more »
4. pftittl on Johnson & Johnson: A Compelling Investment Opportunity: I'm long JNJ, too, as it's a dividend winner. Didn't get in at 46... more »
5. User 489779 on Johnson & Johnson: A Compelling Investment Opportunity: Frank: There are many "good" stocks out there. However, there... more »
6. retiredpharma on Johnson & Johnson: A Compelling Investment Opportunity: Mr Freedland, with all due respect JNJ was a compelling BUY at 46... more »
7. Robert Freedland on Why I Sold Oshkosh: Michael, Excellent points! There is no one system that will work... more »
8. Robert Freedland on Why I Sold Coke and Bought Church & Dwight: Certainly the dividend is an important part of the equation. I... more »
9. Robert Freedland on Why I Sold Coke and Bought Church & Dwight: Great point. Coke might indeed be the "Real Thing". Anyhow,... more »
10. lucky lenny on RIM: Strong Growth in Revenue, Earnings: Robert, u make all good points. My #1 reason for liking RIMM is... more »
11. BioGuy on Medtronic: Apparently Returning to Regular Patterns of Growth: I'm not one for using charts, but it's obvious MDT is a pretty... more »
12. Michael J. White on Why I Sold Oshkosh: In general, we are all emotional traders. See Predictably... more »
13. Uncle Pie on Medtronic: Apparently Returning to Regular Patterns of Growth: It's interesting to look at the Value Line sheet for Medtronic, as... more »
14. Low Sweat Investing on Medtronic: Apparently Returning to Regular Patterns of Growth: I enjoyed this article. MDT is an interesting case from a couple... more »
15. ETFdesk.com on Medtronic: Apparently Returning to Regular Patterns of Growth: You can also look at IHI for broad exposure to the medical device ... more »